EUVIMEDObjevte EUVIMED
KohortenstudieOpen access · CC BY-NC 4.0

A Pilot Study of Porcine Acellular Bladder Matrix Filling in the Treatment of Anal Fistulas: A Single‐Center Cohort Study

Xiang Ma iD, Weisong Xue, Zuolin Zhou, Qiong He, Feng Yang, Ningchao Du, Jun Sun, Huiwen Ning, NiNi Liu, Ying Luo, Jian Cai

ANZ Journal of Surgery · 2025

DOI: 10.1111/ans.70342 ↗

At a glance

Kohortenstudie in ANZ Journal of Surgery, 2025. Written by Xiang Ma and 10 co-authors. Institution: Department of Colorectal Surgery, Shenzhen Second People's Hospital, First Affiliated Hospital of Shenzhen University, Medical Innovation Technology …. Major MEDLINE topics: Rectal Fistula, Urinary Bladder, Biocompatible Materials. Cited 3 times so far (Crossref); 20 references. The full text is freely available (open access, CC BY-NC 4.0). Funded by: Shenzhen Second People's Hospital Clinical Research Fund of Shenzhen High-level Hospital Construction Project.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Objective

This study aimed to preliminarily assess the effectiveness of a novel biomaterial, porcine acellular bladder matrix (PABM), in filling fistula tracts. Summary of Background Data Anal fistula plugs (AFPs) made from biomaterials are designed to fill fistulas, promote tissue healing, and prevent anal sphincter damage caused by conventional surgeries.

Methods

This single‐center cross‐sectional study evaluated PABM‐AFP treatment for anal fistulas between May 2023 and May 2024. Twenty‐eight patients diagnosed with anal fistulas underwent PABM‐AFP filling, with follow‐up conducted for 6–12 months postoperatively.

Results

The overall success rate was 89.3%, with an efficacy rate of 90.6% for all treated fistulas. Of the three patients who experienced treatment failure, two recovered after receiving thread‐ligating treatment, and the remaining patient who had Crohn's disease experienced partial healing. The mean healing time was 5 weeks, and the average follow‐up duration was 7 months. No adverse complications were reported.

Conclusions

PABM‐AFP is a promising, safe, and effective treatment option for anal fistulas. This study provides valuable preliminary data to support the clinical use of PABM‐AFP.

Subjects

MeSH terms (MEDLINE)

Rectal FistulaUrinary BladderBiocompatible MaterialsHumansPilot ProjectsMaleFemaleMiddle AgedAnimalsAdultCross-Sectional StudiesSwineTreatment OutcomeWound HealingAgedFollow-Up StudiesYoung AdultCohort Studies

Author keywords

anal sphincterbiocompatible materialsrectal fistulatissue engineering

Substances

Biocompatible Materials

Authors and institutions

  • Department of Colorectal Surgery, Shenzhen Second People's Hospital, First Affiliated Hospital of Shenzhen University, Medical Innovation Technology Transformation Center of Shenzhen Second People's Hospital, Shenzhen U…

ORCID profiles: Xiang Ma

Funding

  • Shenzhen Second People's Hospital Clinical Research Fund of Shenzhen High-level Hospital Construction Project

Cite

APA

Ma, X., Xue, W., Zhou, Z., He, Q., Yang, F., Du, N., Sun, J., Ning, H., Liu, N., Luo, Y., & Cai, J. (2025). A Pilot Study of Porcine Acellular Bladder Matrix Filling in the Treatment of Anal Fistulas: A Single‐Center Cohort Study. ANZ Journal of Surgery. https://doi.org/10.1111/ans.70342

Vancouver

Ma X, Xue W, Zhou Z, He Q, Yang F, Du N, et al. A Pilot Study of Porcine Acellular Bladder Matrix Filling in the Treatment of Anal Fistulas: A Single‐Center Cohort Study. ANZ Journal of Surgery. 2025. doi:10.1111/ans.70342

BibTeX
@article{Ma2025,
  author = {Ma, Xiang and Xue, Weisong and Zhou, Zuolin and He, Qiong and Yang, Feng and Du, Ningchao and Sun, Jun and Ning, Huiwen and Liu, NiNi and Luo, Ying and Cai, Jian},
  title = {A Pilot Study of Porcine Acellular Bladder Matrix Filling in the Treatment of Anal Fistulas: A Single‐Center Cohort Study},
  journal = {ANZ Journal of Surgery},
  year = {2025},
  doi = {10.1111/ans.70342}
}
Start for free →